- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01972191
Comparison of Three Corneal Horizontal Marking Techniques Using iTrace™
October 23, 2013 updated by: Yonsei University
Before astigmatism reducing surgery, accurate corneal horizontal marking before surgery is important.
Due to new corneal topographic method, iTrace™ surgical workstation, precise evaluation of corneal horizontal marking is available.
In this study the investigators compared three known corneal horizontal making techniques and evaluate accuracy of each methods using iTrace™.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
156
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 102-752
- Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 86 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Who visited professor Tae Im Kim's clinic, department of ophthalmology, Severance hospital.
Description
Inclusion Criteria:
- Patients who were scheduled to have cataract surgery
- Age between 50 to 85 years
Exclusion Criteria:
- With an underlying corneal or conjunctival disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Group 1
Group 1 : Bare eye marking group
|
|
Group 2
Group 2 : Pendulum attached marker group
|
|
Group 3
Group 3 : Horizontal slit beam assisted marker group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The vertical height deviation and rotational axis misalignment amount of each three marking techniques, evaluated by iTrace surgical workstation.
Time Frame: Within 10 minutes after corneal horizontal marking.
|
Nasal and temporal marked spots saved in iTrace surgical workstation program.
|
Within 10 minutes after corneal horizontal marking.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hoffer KJ. Biometry of 7,500 cataractous eyes. Am J Ophthalmol. 1980 Sep;90(3):360-8. doi: 10.1016/s0002-9394(14)74917-7. No abstract available.
- Cha D, Kang SY, Kim SH, Song JS, Kim HM. New axis-marking method for a toric intraocular lens: mapping method. J Refract Surg. 2011 May;27(5):375-9. doi: 10.3928/1081597X-20101005-01. Epub 2010 Oct 15.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
October 15, 2013
First Submitted That Met QC Criteria
October 23, 2013
First Posted (Estimate)
October 30, 2013
Study Record Updates
Last Update Posted (Estimate)
October 30, 2013
Last Update Submitted That Met QC Criteria
October 23, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 1-2013-0049
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Horizontal Marking.
-
ArtialisCompletedUrine Marking | Effects of; SerumBelgium
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency | Horizontal Bone AugmentationEgypt
-
Mansoura UniversityCompleted
-
Ain Shams UniversityCompletedHorizontal Ridge DeficiencyEgypt
-
Mansoura UniversityCompletedHorizontal Alveolar Ridge ResorptionEgypt
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency
-
Cairo UniversityNot yet recruitingHorizontal Ridge Deficiency
-
Cairo UniversityRecruitingHorizontal Ridge DeficiencyEgypt
-
Al-Azhar UniversityRecruitingHorizontal Ridge DeficiencyEgypt
-
Fayoum UniversityEnrolling by invitationHorizontal Ridge DeficiencyEgypt